Even quality stocks such as CTO are getting punished at the moment. I expect to see MON down as it is the norm for this stock as long as I have been following it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025